Advertisement

Rubella

  • Joseph B. Cantey
Chapter

Abstract

Congenital rubella syndrome (CRS) results from fetal infection with rubella virus following primary maternal infection. CRS was initially described in 1941 by Gregg, an Australian ophthalmologist who noted cataracts and congenital heart defects among 71 infants born to mothers who had rubella infection during pregnancy. CRS did not gain widespread recognition until the worldwide rubella pandemic from 1962 to 1964. In the United States during that time, 20,000 infants developed CRS and an additional 10,000 stillbirths occurred. Live-attenuated rubella vaccine was developed in 1969, and routine immunization of young children and at-risk women of childbearing age has markedly reduced the incidence of CRS. Rubella and congenital rubella syndrome were declared eradicated in the United States in 2004 and in the Americas in 2015. However, rubella remains common in other parts of the world, and imported cases of CRS are still seen.

Keywords

Cataract Cardiac malformations Rubella Sensorineural hearing loss 

References

  1. 1.
    Lambert N, Strebel P, Orenstein W, Icenogle J, Poland GA. Rubella. Lancet. 2015;385:2297–307.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Kanaan MN, Farrington CP. Matrix models for childhood infections: a Bayesian approach with applications to rubella and mumps. Epidemiol Infect. 2005;133:1009–21.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Lebo EJ, Kruszon-Moran DM, Marin M, et al. Seroprevalence of measles, mumps, rubella, and varicella antibodies in the United States population, 2009-2010. Open Forum Infect Dis. 2015;20:ofv006.CrossRefGoogle Scholar
  4. 4.
    Hyde TB, Kruszon-Moran D, McQuillan GM, et al. Rubella immunity levels in the United States population: has the threshold of viral elimination been reached? Clin Infect Dis. 2006;43(S3):S146–50.CrossRefPubMedGoogle Scholar
  5. 5.
    Dykewicz CA, Kruszon-Moran D, McQuillan GM, et al. Rubella seropositivity in the United States, 1988-1994. Clin Infect Dis. 2001;33:1279–86.CrossRefPubMedGoogle Scholar
  6. 6.
    Seither R, Calhoun K, Street EJ, et al. Vaccination coverage for selected vaccines, exemption rates, and provisional enrollment among children in kindergarten—United States, 2016-17 school year. MMWR. 2017;66:1073–80.PubMedPubMedCentralGoogle Scholar
  7. 7.
    Walker TY, Elam-Evans LD, Singleton JA, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years—United States, 2016. MMWR. 2017;66:874–82.PubMedPubMedCentralGoogle Scholar
  8. 8.
    Papania MJ, Wallace GS, Rota PA, et al. Elimination of endemic measles, rubella, and congenital rubella syndrome from the Western hemisphere: the US experience. JAMA Pediatr. 2014;168:148–55.CrossRefPubMedGoogle Scholar
  9. 9.
    Vynnycky E, Adams EJ, Cutts FT, et al. Using seroprevalence and immunization coverage data to estimate the global burden of congenital rubella syndrome, 1996-2010: a systematic review. PLoS One. 2016;11:e0149160.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Cradock-Watson JE, Miller E, Ridehalgh MK. Detection of rubella virus in fetal and placental tissues and in the throats of neonates after serologically confirmed rubella in pregnancy. Prenat Diagn. 1989;9:91–6.CrossRefPubMedGoogle Scholar
  11. 11.
    Miller E, Cradock-Watson JE, Pollock TM. Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet. 1982;2:781–4.CrossRefPubMedGoogle Scholar
  12. 12.
    Collins IS. The incidence of congenital malformations following maternal rubella at various stages of pregnancy. Med J Aust. 1953;2:456–8.PubMedGoogle Scholar
  13. 13.
    Gregg NM. Congenital cataract following German measles in the mother. Trans Ophthal Soc Austr. 1941;3:35–44.Google Scholar
  14. 14.
    Givens KT, Lee DA, Jones T, Ilstrup DM. Congenital rubella syndrome: ophthalmic manifestations and associated systemic disorders. Br J Opthalmol. 1993;77:358–63.CrossRefGoogle Scholar
  15. 15.
    Overall JC. Intrauterine virus infections and congenital heart disease. Am Heart J. 1972;84:823–33.CrossRefPubMedGoogle Scholar
  16. 16.
    Wild NJ, Sheppard S, Smithells RW, Holzel H, Jones G. Onset and severity of hearing loss due to congenital rubella infection. Arch Dis Child. 1989;64:1280–3.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Munoz FM. Maternal immunization: an update for pediatricians. Pediatr Ann. 2013;42:153–8.CrossRefPubMedGoogle Scholar
  18. 18.
    Bullens D, Smets K, Vanhaesebrouck P. Congenital rubella syndrome after maternal reinfection. Clin Pediatr. 2000;39:113–6.CrossRefGoogle Scholar
  19. 19.
    Centers for Disease Control and Prevention. Control and prevention of rubella: evaluation and management of suspected outbreaks, rubella in pregnant women, and surveillance for congenital rubella syndrome. MMWR Recomm Rep. 2001;50(RR-12):1–23.Google Scholar
  20. 20.
    Grose C, Itani O, Weiner CP. Prenatal diagnosis of fetal infection: advances from amniocentesis to cordocentesis—congenital toxoplasmosis, rubella, cytomegalovirus, varicella virus, parvovirus, and human immunodeficiency virus. Pediatr Infect Dis J. 1989;8:459–68.CrossRefPubMedGoogle Scholar
  21. 21.
    Jin L, Thomas B. Application of molecular and serological assays to case based investigations of rubella and congenital rubella syndrome. J Med Virol. 2007;79:1017–24.CrossRefPubMedGoogle Scholar
  22. 22.
    Hubschen JM, Bork SM, Brown KE, et al. Challenges of measles and rubella laboratory diagnostics in the era of elimination. Clin Microbiol Infect. 2017;23:511–5.CrossRefPubMedGoogle Scholar
  23. 23.
    Centers for Disease Control and Prevention. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2013;62(RR-4):13.Google Scholar
  24. 24.
    Centers for Disease Control and Prevention. Rubella vaccination during pregnancy—United States, 1971-1988. MMWR. 1989;38:289–93.Google Scholar
  25. 25.
    Yamada T, Mochizuki J, Hanaoka M, et al. Effects of campaign for postpartum vaccination on seronegative rate against rubella among Japanese women. BMC Infect Dis. 2014;14:152.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Vilajeliu A, Garcia-Basteiro AL, Valencia S, et al. Rubella susceptibility in pregnant women and results of a postpartum immunization strategy in Catalonia, Spain. Vaccine. 2015;33:1767–72.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Divisions of Neonatal/Perinatal Medicine and Pediatric Infectious Diseases, Department of PediatricsUniversity of Texas Health Science Center San AntonioSan AntonioUSA

Personalised recommendations